Toll-like receptor 2 ligands as adjuvants for human Th1 responses

被引:85
|
作者
Sieling, PA
Chung, W
Duong, BT
Godowski, PJ
Modlin, RL
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol & Immunol, Div Dermatol, Los Angeles, CA 90095 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源
JOURNAL OF IMMUNOLOGY | 2003年 / 170卷 / 01期
关键词
D O I
10.4049/jimmunol.170.1.194
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bacterial lipopeptides (bLPs) are increasingly used as adjuvants to activate cell-mediated immune responses to foreign Ags. To explore mechanisms whereby bLPs adjuvant T cell responses, we stimulated human PBMCs with bLPs. We found that bLPs stimulate T cells to proliferate and produce IFN-gamma in an accessory cell-dependent manner and in the absence of exogenous protein Ags. The ability of bLPs to stimulate T cell proliferation was Toll-like receptor 2 dependent and required IL-12, interaction with costimulatory molecules, and MHC proteins. Our data suggest that bLPs adjuvant adaptive Th1 responses by enhancing Ag presentation of endogenous peptides.
引用
收藏
页码:194 / 200
页数:7
相关论文
共 50 条
  • [31] Toll-like receptor agonists as cancer vaccine adjuvants
    Jeon, Donghwan
    Hill, Ethan
    Mcneel, Douglas G.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [32] Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines
    Farina, C
    Theil, D
    Semlinger, B
    Hohlfeld, R
    Meinl, E
    INTERNATIONAL IMMUNOLOGY, 2004, 16 (06) : 799 - 809
  • [33] Porcine B Cell Subset Responses to Toll-like Receptor Ligands
    Braun, Roman Othmar
    Python, Sylvie
    Summerfield, Artur
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [34] Determinants of Divergent Adaptive Immune Responses after Airway Sensitization with Ligands of Toll-Like Receptor 5 or Toll-Like Receptor 9
    Lee, Linda M.
    Ji, Ming
    Sinha, Meenal
    Dong, Matthew B.
    Ren, Xin
    Wang, Yanli
    Lowell, Clifford A.
    Ghosh, Sankar
    Locksley, Richard M.
    DeFranco, Anthony L.
    PLOS ONE, 2016, 11 (12):
  • [35] Evaluation of toll-like receptor ligands as adjuvants for an epitope-based therapeutic HPV vaccine
    Khallouf, Hadeel
    Mangei, Jasmin
    Blatnik, Renata
    Hoppe, Stephanie
    Steinbach, Alina
    Riemer, Angelika B.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [36] Exposure to HIV-1-encoded Toll-like receptor 8 ligands enhances monocyte response to microbial encoded Toll-like receptor 2/4 ligands
    Mureith, Marianne W.
    Chang, J. Judy
    Lifson, Jeffrey D.
    Ndung'u, Thumbi
    Altfeld, Marcus
    AIDS, 2010, 24 (12) : 1841 - 1848
  • [37] Toll-like receptor responses in tuatara
    La Flamme, Anne Camille
    de Thierry, Danielle
    O'Neill, Shay
    Miller, Hilary
    NEW ZEALAND JOURNAL OF ZOOLOGY, 2010, 37 (03) : 235 - 242
  • [38] Estrogen Receptor Alpha Modulates Mesangial Cell Responses to Toll-Like Receptor Ligands
    Svenson, John
    Cunningham, Melissa
    Dasgupta, Subhajit
    Gilkeson, Gary S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 348 (06): : 492 - 500
  • [39] Toll-like receptor (TLR)9 regulates TH1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium Tuberculosis
    Bafica, Andre
    Scanga, Charles
    Feng, Carl
    Sher, Alan
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 344 - 344
  • [40] Human mast cell responses to toll-like receptor activators
    McCurdy, JD
    Olynych, T
    Lin, TJ
    Marshall, JS
    ALLERGY FRONTIERS AND FUTURES, 2003, : 126 - 129